Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pediatric Selective Cytopheretic Device (SCD-PED, QUELIMMUNE) for Critically Ill Children With Acute Kidney Injury: A Humanitarian Device Exemption (HDE) Surveillance Registry Protocol

NCT06517810 is registered in ClinicalTrials.gov with SeaStar Medical as lead sponsor.

NCT NCT06517810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06517810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pediatric Selective Cytopheretic Device (SCD-PED, QUELIMMUNE) for Critically Ill Children With Acute Kidney Injury: A Humanitarian Device Exemption (HDE) Surveillance Registry Protocol
Lead sponsor
SeaStar Medical
Phase
Observational
Overall status
Recruiting
Start date
July 19, 2024
Completion date
August 31, 2026
Enrollment
50 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, acute kidney injury due to sepsis